Scientific paper Synthesis, Characterization and Antimicrobial Study of Novel 4-{[(8-Hydroxyquinolin-5-yl)methyl]amino}benze- nesulfonamide and Its Oxinates Satish F. Vanparia,2 Tarosh S. Patel,2 Natvar A. Sojitra,2 Chandresh L. Jagani,2 Bharat C. Dixit,2 Pradeep S. Patel1 and Ritu B. Dixit1* 1 Ashok & Rita Patel Institute of Integrated Study & Research in Biotechnology and Allied Sciences, New Vallabh Vidyanagar - 388 121, Gujarat, India. 2 Chemistry Department, V P. & R. P. T. P. Science College, Vallabh Vidyanagar - 388 120, Gujarat, India. * Corresponding author: E-mail: dixits20002003@yahoo.co.in Received: 08-09-2009 Abstract A novel 4-{[(8-hydroxyquinolin-5-yl)methyl]amino}benzenesulfonamide (HQMABS) was synthesized by optimized reaction of 4-aminobenzenesulfonamide with 5-chloromethyl-8-hydroxyquinoline hydrochloride (CMHQ). Various oxinates of HQMABS were also prepared using Mn(II), Fe(II), Co(II), Ni(II), Cu(II), and Zn(II) metal salts. All compounds were analyzed by physicochemical, thermogravimetric and spectroscopic techniques. Antimicrobial activity was carried out using agar-plate method against various strains of bacteria (Staphylococcus aureus, Bacillus subtillis, Pseudomonas aerugionsa, and Escherichia coli) and spores of fungi (Aspergillus niger and Aspergillus flavous). The results showed significantly higher antimicrobial activity of HQMABS compared to the parent 8-hydroxyquinoline and sulfonamide, while oxinates of HQMABS showed milder activity. Keywords: 8-Hydroxyquinoline (oxine), sulfonamide, oxinates, antibacterial and antifungal activity. 1. Introduction Among the hydroxyquinolines, the chemistry of 8-hydroxyquinolines (8HQs) has drawn considerable attention due to their diverse biological properties1,2 such as an-tiamoebic,3,4 antiseptic and disinfectant,5,6 antimalarial,7 antiallergic,8 antitubercular,9 pesticidal,10 antiplaque,11 antineoplastic,12 anticancer,13 antileishmanial14 and antifungal efficiency.15-17 8HQ has been found to be non-carcinogenic and is employed for in vitro assays as well as genetic toxicity.18 It also has remarkable effects similar to the antibiotic lomofugin, which rapidly and selectively inhibits the RNA synthesis in yeast.19 Iron bound to the lipophilic chelator (8HQ), results in substantial DNA-strand breakage of cultured human lung cells.20 Biological and pharmacological chelating agents like 8-hydroxyquinoline based ligands and chelates are in progress in coordination studies.21 8HQs showed the above mentioned biological properties, which might be due to their ability to chelate with the metal ions, essential for metabolism,17 where OH group of 8HQ acts as an acid. The metal chelates of 8HQs (oxinates) were reported to be biologically active due to their lipid solubility and possess comparable activity against bacteria and fungi. The activity of oxinates could be explained by assuming that these complexes first penetrate the cell-wall due to their lipid solubility and at the site of action undergoes dissociation to 1:1 8HQ complex which will then become a toxic entity by combining with the metal binding sites of enzymes as well as by blocking the same.22,23 In addition to these, due to the excellent pharmacological activities, the synthetic antibacterial sulfonamides have been well-known since 1935, but their toxicity and microbial resistance do not allow them to be used in the treatment of disease.17 Thus, looking to the prominent biological activities of sulfonamides and 8-hydroxyquinoline derivatives, it was thought interesting to bring these two biologically active moieties within a single molecular framework, with a view to study their additive effects on the chemical and biological properties. Therefore, the present communication comprises synthesis, characterization and comparative biological study of 4-{[(8-hydroxyquinolin-5-yl) methyl]amino}benzenesulfonamide and its oxinates. 2. Experimental 2. 1. Materials and Methods All the chemicals used were of analytical grade and purified by standard methods prior to use. Nutrient- HCI OH 0=S=0 CMHQ NH2 TEA CH3CN w H OH HQMABS aqueous HCOOH M(ll) solution U o=s=o NH2 Where M= Mn(ll), Fe(ll), Co(ll), Ni(ll), Cu(ll) and Zn(ll) Scheme 1: Proposed route for the synthesis of HQMABS and [M(HQMABS)2(H2O)2]. agar, potato dextrose agar and sulphanilamide were purchased from Hi-Media Chemicals, India. Chloride, nitrate, and sulphate metal(II)-salts were used in their hydrated form. Silica gel F254 TLC plates (20 x 20 cm) were purchased from Merck (India). The elemental analyses were performed with Vario EL CHN elemental analyzer. The FT-IR spectra were recorded on Perkin Elmer Spectrum GX spectrophotometer using KBr pellets. The :H and 13C (APT) NMR spectra were recorded on Bruker 400 MHz instrument using DMSO-d6 as solvent, and TMS as internal reference standard. The MS-CI spectrum of HQMABS was recorded on Shimadzu LC-MS 2010 eV spectrometer in acetonitrile. Diffuse electronic spectra were recorded on Beckman DK-2A spectrophotometer using MgO as a reference. Magnetic moments were determined by the Gouy method using mercury tetrathioc-yanatocobaltate(II) [HgCo(NCS)4] as calibrant (%g = 1644 x 10-6 cgs units at 20 °C) and the diamagnetic correction was made using Pascal's constant.24 The thermo-gravimetric analyses were carried out using Perkin Elmer Thermogravimetry Analyzer at a heating rate of 10 °C per minute in air. The metal contents of the complexes were analyzed by EDTA titration after decomposing the organic matter with HClO4, H2SO4 and HNO3 (1:1.5:2.5) mixture.25 The melting point of HQMABS was checked by standard open capillary method and is uncorrected. The ligand HQMABS was synthesized using 5-chloromethyl-8-hydroxyquinoline hydrochloride4 (CMHQ) as a starting material by the modification of reported method26 and its metal(II) complexes were synthesized using previously reported procedure.27 The outline for the synthesis of HQMABS and its M(II) oxinates is shown in Scheme 1. 2. 2. Synthesis of 4-{[(8-Hydroxyquinolin-5-yl)methyl]amino}benzenesulfonamide (HQMABS) To a solution of 4-aminobenzenesulphonamide (7.11 g, 41.34 mmol) and triethylamine (9.68 g, 95.61 mmol) in acetonitrile (75 ml), 5-chloromethyl-8-hydro-xyquinoline hydrochloride (10 g, 43.45 mmol) was added slowly in portions at room temperature under continuous stirring and refluxed for 2 hours. The reaction mixture was then poured into ice-cold water to afford off-white solid, which was filtered, washed with hot water, and crystallized from ethanol. Isolated crystals were dried under vacuum to obtain colorless crystals of HQMABS. Rf = 0.65, chloroform: methanol: ammonia (70:29:1). Yield, 9.96 g (87.8%); m.p. = 287 °C; MS-CI, m/z 330.0 (M+H) for C16H15N3O3S (329.40). The physicochemical parameters, characteristic FT-IR frequencies, and NMR spectral data (1H and 13C) are presented in Tables 1-3. 2. 3. Synthesis of metal(II) oxinates [M(II)(HQMABS)2(H2O)2; M = Mn(II), Fe(II), Co(II), Ni(II), Cu(II), Zn(II)] A hot solution of metal(II) salt (2.5 mmol) in 50% aqueous formic acid (2.5 ml) was added drop-wisely with continuous stirring to the hot 20% aqueous formic acid solution (20 ml) of HQMABS (5 mmol). With the proper adjustment of the pH (~8.5) using 50% NH4OH solution, the resultant mixture was further digested for 4 hours in the water bath. The obtained solid product was filtered, washed with hot water, and subsequently with small quantity of ethanol, acetonitrile, and dried in a vacuum desiccator. The physicochemical parameters, and characteristic FT-IR frequencies of metal(II) oxinates are summarized in Tables 1-2. 3. Results and Discussion 5-Chloromethyl-8-hydroxyquinoline hydrochloride (CMHQ) was prepared by chloromethylation of 8-hy-droxyquinoline. Considerable difficulties were faced to obtain high purity of CMHQ even after washing the crude CMHQ by concentrated hydrochloric acid and acetone.4 Another obstacle while working with CMHQ was the use of inorganic base catalysts like sodium/potassium bicarbonate, sodium/potassium hydrogen carbonate, and sodium hydroxide. They leads to either a slow reaction or produce 5-hydroxymethyl-8-hydroxyquinoline in quantitative yield.4 To overcome these obstacles a triethylamine (TEA) was used as a scavenger in the formation of HQMABS in a quantitative yield while reacting CMHQ with sulphanilamide. The synthesized 4-{[(8-hydroxyquinolin-5-yl) methyl]amino}benzenesulfonamide (HQMABS) appears as colourless crystals. It is partially soluble in acetone, methanol, ethanol and acetonitrile, while it is soluble in polar organic solvents like dimethylformamide (DMF), di-methylsulphoxide (DMSO), organic acids and pyridine. All metal(II) oxinates [M(II)(HQMABS)2(H2O)2] have characteristic colour, are stable in air, and are practically insoluble in water, ethanol, methanol, chloroform and hexane. On the other hand, slight solubility has been observed in DMF as well as in DMSO, and was difficult to obtain single crystal suitable for the X-ray diffraction analysis. 3. 1. Characterizations The Mass spectrum of HQMABS was recorded in acetonitrile as solvent using chemical ionization technique and the molecular ion peak was observed at m/z 330.0, which confirmed the proposed molecular formula C16H15N3O3S of the ligand. The results of elemental analysis of ligand HQMABS and it's metal(II) oxinates are given in Table 1 t m a a £ g h cocoin';tvqvq I>I>I>!>I>I>I>I>oooooooo CO ^ O O CO O CO 0> 00 VO CO vqr^vqinin^inininxin^^in ^ ^ cn in m ^ co in co ^incococo^fNcofN^^n^c^co in Figure 2. Thermogravimetric curves of HQMABS and its oxinates. follows single-step thermal decomposition. The initial weight loss of 1% might be due to loosely held solvent in HQMABS. Up to 74% of the weight loss commenced in the range of 150-550 °C and further slow degradation took place up to 900 °C. Similarly, examination of the TGA data of oxinates showed two-step thermal decomposition. The initial weight loss may be due to the solvent molecules or loosely held moisture trapped inside the oxinates, whereas the weight loss observed in the range of 125-180 °C may be attributed to the two coordinated water molecules.42 This also satisfies the six coordination sites of the metal ions in metal(II) oxinates. For metal(II) oxinates the maximum weight loss has been observed in the temperature range of 210-900 °C, and the remaining weight corresponds to a mixture of metal oxide and some ashes as ultimate pyrolysis products. There is also a remarkable difference in the mode of thermal degradation for HQMABS and its oxinates. [M(II)(HQMABS)2(H2O)2] have shown fast decomposition pattern as compared to HQMABS. These results of thermal behavior can be explained by the fact that the decomposition of chelates was catalytically induced by the metal ions.43 The energy of activation (Ea) for thermal decomposition of HQMABS and its oxinates was estimated by the reported method using following equation:44 ln[ln(1/y)] = (Ea/RT + 1) ln T + constant Ea was computed from the slope (-Ea/R) of the plot of ln[ln (1/y)] versus (ln T), and is given in Table 1. The energy of activation for HQMABS has been found to be 12 kcal/mol, while the activation energy for oxinates is between 8.8-10.9 kcal/mol. 3. 6. Antimicrobial Activity The synthesized ligand 4-{[(8-hydroxyquinolin-5-yl)methyl]amino}benzenesulfonamide (HQMABS) and its oxinates [M(II)(HQMABS)2(H2O)2] were subjected for their in vitro antimicrobial activity against the grampositive bacteria (Staphylococcus aureus and Bacillus subtillis), gram-negative bacteria (Pseudomonas aeru-gionsa and Escherichia coli) by using agar nutrient as medium, and against fungi (Aspergillus niger and Aspergillus flavous) using potato dextrose agar as medium. A stock solution was prepared by dissolving compounds in DM-SO as 10% solution. The antibacterial and antifungal activities were performed at a concentration of 25 ^g/ml, using agar-plate method,45 and DMSO as control for comparison of antibacterial and antifungal activities with parent 8HQ and sulphanilamide. The results of measured zone of inhibition (in mm) of comparative biological study for HQMABS and its oxinates against each of species are summarized in Table 4. Table 4. Antimicrobial activities of studied compounds. Compound Zone of inhibition, mma S.aureus B.subtillis E.coli P.aerugionsa A.niger A.flavous HQMABS 34 35 31 28 37 32 Sulphanilamide 18 14 20 19 24 22 8HQ 24 22 26 22 21 19 [Mn(HQMABS)2(H2O)2] 16 13 13 14 12 11 [Fe(HQMABS)2(H2O)2] 22 19.5 21 19 23 21 [Co(HQMABS)2(H2O)2] 17 15 16 17 13.5 18 [Ni(HQMABS)2(H2O)2] 18 16 14 19 17 15 [Cu(HQMABS)2(H2O)2] 19.5 22 21 20 20 19.5 [Zn(HQMABS)2(H2O)J 13 15 11 12 12 15 a Zone of inhibition obtained upon extraction of control (DMSO) = 11. Results of antimicrobial study revealed that ligand HQMABS exhibited higher activity than parent molecules (sulphanilamide, 8HQ, and oxinates). The enhancement of the antimicrobial activity of HQMABS might be due to the synergetic effect17 of sulphanilamide and 8HQ. The membrane of gram-positive bacteria allows 8HQs to transfer the metal across the intact plasma membrane of endothelial cells rapidly and increase their sensitivity. The outer membrane of gram-negative bacteria might serve as a selective barrier for 8HQs, obstructing their passage in the cell and hence show lesser sensitivity. Therefore, it is presumed that HQMABS exert their biological activities similarly to 8HQ as a membrane-active agent through metal-ion chelation.46 The biological activity of compounds also depends on the nature of the ligand, concentration, li-pophilicity, nature of metal ion, coordinating sites and geometry of the complex. As the mechanism of inhibition by 8HQs and oxinates might be different, it was observed that all the M(II) oxinates showed moderate or lesser activity as compared to HQMABS. 4. Conclusion The novel 4-{[(8-hydroxyquinolin-5-yl)methyl] amino}benzenesulfonamide (HQMABS) and its octahedral metal(II) oxinates (1 : 2 metal to ligand ratio) were synthesized and characterized, and showed good antibacterial and antifungal activities compared to 8-hydroxyqui-noline and sulphanilamide. This might be due to the additive biological effect of parent molecules and/or due to the metal chelating properties. Among the oxinates, Fe(II) and Cu(II) chelates showed better activity, but were found less active than HQMABS. 5. Acknowledgements The authors gratefully acknowledge the financial support for this work by the TWAS [UNESCO FR: 08-025RG/CHE/AS], Italy. We are also thankful to C. V. M. and the Director, ARIBAS, New Vallabh Vidyangar for providing necessary research facilities. 6. References 1. W. McKeehan, L. C. Lappas, J. Pharm. Sci., 1963, 53, 695-713. 2. J. L. Pierre, P. Baret, G. Serratrice, Curr. Med. Chem., 2003, 10, 1077-1084. 3. S. Singh, N. Bharti, P. P. Mohapatra, Chem. Rev., 2009, 109, 1900-1947. 4. J. H. Burckhalter, R. I. Leib, J. Org. Chem., 1961, 26, 4078-4083. 5. A. S. Yanni, A. M. Mohharam, J. Chem. Tech. Biotech., 1990, 49, 243-247. 6. G. Franchi, P. Vigni, IL Farmaco, 1967, 22, 923-928. 7. N. T. Huy, D. T. Uyen, A. Maeda, D. T. X. Trang, T. Oida, S. Harada, K. Kamei, Antimicrob. Agents Chemother. 2007, 51, 350-353. 8. R. Mekheimer, E. K. Ahmed, A. F. Khattab, Bull. Chem. Soc. Japan, 1998, 66, 2936-2940. 9. F. Fugikawa, K. Hirai, T. Toyota, R. Tamada, S. Kijun, M. Naito, S. Tsukuma, Y. Zasshi, J. Med. Chem., 1967, 87, 844-849. 10. S. J. Blunden, B. N. Patel, P. J. Smith, B. Sugavanam, Appl. Organomet. Chem., 1987, 1, 241-245. 11. V. D. Warner, J. D. Musto, J. N. Sane, K. H. Kim, G. L. Grunewald, J. Med. Chem., 1977, 20, 92-98. 12. M. Yamato, J. Ando, K. Sakaki, K. Hashigaki, Y. Wataya, S. Tsukagoshi, T. Tashiro, T. Tsuruo, J. Med. Chem., 1992, 35, 267-272. 13. A. Z. El-Sonbati, A. F. Shoair, R. M. Younes, Chem. Pharm. Bull., 2001, 49, 1308-1313. 14. Z. Darbari, M. Lemnari, A. Bahloul, A. Sebban, M. Hassar, S. Kitane, M. Berrada, M. Boudouma, Il Farmaco, 2004, 59, 195-199. 15. B. K. Deb, A. K. Ghosh, Can. J. Chem., 1987, 65, 1241-1248. 16. H. Gershon, M. W. McNeil, R. Parmegiani, P. K. Godfrey, J. Med. Chem, 1972, 15, 987-994. 17. J. H. Block, J. M. Beale, Wilson and Giswolid's Textbook of Organic Medicinal and Pharmaceutical Chemistry, 11th Ed., Lippincott Williams and Wilkins, Philadelphia, 2005. 18. R. W. Tennant, B. H. Margolin, M. D. Shelby, E. Zeiger, J. Spalding, W. Caspary, M. Resnick, S. Stasiewicz, B. Anderson, R. Minor, Science, 1987, 236, 933-948. 19. R. S. S. Fraser, J. Creanor, Eur. J. Biochem., 1974, 46, 6773. 20. P. Leanderson, C. Tagesson, Carcinogenesis, 1996, 17, 545-558. 21. O. Osetska, R. Fröhlich, M. Albrecht, Eur. J. Org. Chem., 2007, 29, 4902-4908. 22. A. S. A. Zidan, J. Therm. Anal. Calorim., 2002, 68, 10451052. 23. Y. Anjaneyulu, R. Y. Swamy, R. P. Rao, Proc. Ind. Acad. Sci., 1984, 93, 131-138. 24. A. Weiss, H. Witte, Magnetochemie, Verlag Chemie, Weinheim, 1973. 25. G. H. Jeffery, J. Bassett, J. Mentham, R. C. Denney, Vogel's Text Book of Quantitative Inorganic Analysis, 6th Ed., Longman, Harlow, 1989. 26. R. Peng, F. Wang, Y. Sha, Molecules, 2007, 12, 1191-1198. 27. T. B. Shah, B. C. Dixit, R. B. Dixit, J. Therm. Anal. Calorim., 2008, 92, 505-512. 28. R. M. Silverstein, F. X. Webster, Spectrometric Identification of Organic Compounds, 6th Ed., Wiley Interscience, New York, 2004. 29. H. Nakamura, T. Yoshida, M. Todoko, K. Ueno, M. Takagi, Bull. Chem. Soc. Japan, 1984, 57, 2839-2845. 30. K. Nakamoto, Infrared Spectra of Inorganic and Coordination Compounds, Part B, 5th Ed., Wiley Interscience, New York, 1997. 31. V. Sadasivam, M. Alaudeen, Indian J. Chem., Sect. A: Inorg., Bio-inorg., Phys., Theor. Anal. Chem., 2007, 46A, 19591964. 32. R. G. Charles, H. F. Frieser, R. Priedel, L. E. Hilliand, R. D. Johnston, Spectrochim. Acta, 1956, 8, 1-8. 33. K. C. Satpathy, A. K. Pande, R. Mishra, I. Panda, Synth. React. Inorg., Met.-Org., Nano-Met. Chem., 1991, 21, 531538. 34. J. M. Kauffmann, M. Alafandy, R. Willem, B. Mahieu, M. Alturky, M. Biesemans, F. Legros, F. Camu, M. Gielen, Inorg. Chim. Acta, 1997, 255, 175-182. 35. J. Kidric, D. Hadzi, D. Kocjan, V. Rutar, Org. Magn. Reson., 1981, 15, 280-284. 36. J. A. Iggo, NMR Spectroscopy in Inorganic Chemistry, Oxford University Press, New York, 1999. 37. A. Majumder, G. M. Rosair, A. Mallick, N. Chattopadhyay, S. Mitra, Polyhedron, 2006, 25, 1753-1759. 38. K. M. Reddy, H. P. Halli, A. C. Hiremath, J. Indian Chem. Soc., 1994, 71, 751-756. 39. A. Kriza, L. Pricop, A. Meghean, N. Stanica, J. Indian Chem. Soc., 2001, 78, 448-453. 40. N. Raman, C. Thangaraja, S. J. Raja, Indian J. Chem., Sect. A: Inorg., Bio-inorg., Phys., Theor. Anal. Chem., 2005, 44A, 693-704. 41. J. C. Bailer, M. L. Judd, J. McLean, J. Coord. Polym. WADC, Tech. Rep. Part-II., 1959, 116, 51-58. 42. A. V. Nikolaev, V. A. Logvinenko, L. T. Myachina: Thermal Analysis, Academic Press, New York, 1960. 43. R. C. DeGeiso, L. G. Donaruma, E. A. Tomic, J. Appl. Polym. Sci., 1965, 9, 411-416. 44. A. Brido, J. Polym. Sci., 1967, 7, 1761-1767. 45. M. J. Pelzar, E. C. S. Chan, N. R. Krieg, Antibiotics and other Chemotherapeutic Agents in Microbiology, 5th Ed., Blackwell Science, New York, 1998. 46. A. Y. Shen, C. P. Chen, S. Raffler, Life Sci., 1999, 64, 813-825. Povzetek V prispevku je opisana priprava 4-{[(8-hidroksikinolin-5-il)metil]amino}benzensulfonamida (HQMABS) z optimizirano reakcijo med 4-aminobenzensulfonamidom in 5-klorometil-8-hidroksikinolin hidrokloridom. Z uporabo kovinskih soli ionov Mn(II), Fe(II), Co(II), Ni(II), Cu(II) in Zn(II) so bili pripravljeni tudi različni oksinati HQMABS. Vse spojine so bile analizirane in okarakterizirane z fizikalno-kemijskimi, termo-gravimetričnimi in spektroskopskimi tehnikami. Prav tako je bila testirana protimikrobna aktivnost pripravljenih spojin na različnih bakterijah (Staphylococcus aureus, Bacillus subtillis, Pseudomonas aerugionsa in Escherichia coli) in sporah gob (Aspergillus niger in Aspergillus fla-vous). Rezultati so pokazali precej višjo protimikrobno aktivnost HQMABS kot pri 8-hidroksikinolinu in sulfonamidu, medtem ko oksinati HQMABS kažejo zmerno aktivnost. Supplementary Material NMR spectra (1H and 13C APT) of HQMABS and [Zn(HQMABS)2(H2O)2] Figure 1.13C NMR APT spectrum of HQMABS. Figure 2. !H NMR spectrum of HQMABS. Figure 3. 13C NMR (APT) spectrum of [Zn(HQMABS)2(H2O)2]. Figure 4. 'H NMR spectrum of [Zn(HQMABS)2(H2O)2]. Diffuse electronic spectra: 200 400 600 800 1000 1200 Wavelength (run) Figure 5. Diffuse electronic spectra of M(II)-oxinate. Magnetic properties data Magnetic Susceptibility (^eff) calculation Calibration of gouy tube 1. Weight of the empty gouy tube without magnetic field (a) = 11.50826 gm. 2. Weight of the empty gouy tube with magnetic field (b) = 11.50338 gm. 3. Apparent change in weight (b - a) = (- c) = y - 0.00488 gm. 4. Weight of tube + water (d) = 11.96516 gm. 5. Weight of water = Volume of water (d - a) = V = 0.4569 gm. 6. Weight of tube + calibrant without magnetic field (e) = 12.09474 gm. 7. Weight of tube + calibrant with magnetic field (f) = 12.13664 gm. 8. Weight of calibrant (e - a) = W = 0.58648 gm. 9. Apparent change in weight (f - e) = dw = 0.0419 gm. 10. Apparent change in weight with diamagnetic correction = (f - e) - (- c) = w = 0.04678 gm. Tube constant P was determined from the following equation. - JfW-kV Y ~ - W Where, % = Magnetic susceptibility of the calibrant Hg[Co(CNS)4] = 16.44 x 10-6 at 20 °C W = Weight of calibrant k = Volume susceptibility of air = 0.029 x 10-6 V = Volume of water w = Apparent change in weight p _ [£16.44 X lir6)0.55643] - [(G.Q29 X lQ_t) 0.4&63] (3 = 2.05811 x lO^4 Magnetic susceptibility (^eff) calculation for Cu complex 11.Weight of the tube + compound without magnetic field (g) = 11.80136 gm. 12. Weight of the tube + compound with magnetic field (h) = 11.79918 gm. 13.Weight of compound = (g - a) = W = 0.2931 gm. 14. Apparent change in weight = (h - g) = dw = -0.00218 gm. 15. Apparent change in weight with diamagnetic correction = (h - g) - (- c) = w w = 0.002700 gm. Magnetic susceptibility of the compound determined from the following equation. kV + pw iT" Where, W = Weight of compound w = Apparent change in weight P = Tube constant _ [£0.029 X 10*) 0.4569] + [(2,05311 X 10'*) 0.002700] ^ 0.2931 Hg= 1.94111 x 10~6 gm. M-m = x Molecular Weight of compound Where, Molecular Weight of Cu Complex = 756.29 gm. = 1.94111 x 10-6x 756.29 = 1.46804 x 10-3 gm. Where T = Absolute temperature = 298 °K Pn, = 2.S3V 1.46304X 10 s X29S M.eff = 1.8718 B.M. NOTE : Magnetic susceptibility (^eff) calculations for Mn(II), Fe(II), Co(II) and Ni(II) complex were obtained similarly.